Skip to main content
SpringerLink
Log in

Tumorassoziierte Hyperkalzämie

Behandlungsstrategien für den onkologischen Notfall

  • Supportivtherapie
  • Published:
Im Fokus Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Chen Q et al. Concurrent bronchial artery and posterior inferior cerebellar artery microcatheter Interventional chemotherapy for adenocarcinoma of the lung with solitary cerebellar metastasis. Med Sci Monit. 2019;25:6504-11

  2. Chukir T et al. Calcitriol elevation is associated with a higher risk of refractory hypercalcemia of malignancy in solid tumors. J Clin Endocrinol Metab. 2019;105(4):e1115-23

  3. Higdon ML et al. Oncologic emergencies: recognition and initial management. Am Fam Physician. 2018;97(11):741-8

  4. Asonitis N et al. Diagnosis, pathophysiology and management of hypercalcemia in malignancy: a review of the literature. Horm Metab Res. 2019;51(12):770-8

  5. Klemencic S, Perkins J. Diagnosis and management of oncologic emergencies. West J Emerg Med. 2019;20(2):316-22

  6. Kohart NA et al. Animal models of cancer-associated hypercalcemia. Veterinary Sci. 2017;4(2):21

  7. Ramos REO et al. Malignancy-related hypercalcemia in advanced solid tumors: survival outcomes. J Globl Oncol. 2017;3(6):728-33

  8. Johnson K et al. Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report. BMC Urol. 2021;21(1):51

  9. Verhoef M-J et al. Palliative care needs of advanced cancer patients in the emergency department at the end of life: an observational cohort study. Support Care Cancer. 2020;28(3):1097-107

  10. Aielli F et al. Bone metastasis pain, from the bench to the bedside. Int J Mol Sci. 2019;20(2):280

  11. Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. North Am J Med Sci. 2015;7(11):483-93

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin II | Onkologischen Zentrum, Krankenhaus Martha-Maria Halle-Dölau, Röntgenstraße 1, 06120, Halle (Saale), Deutschland

    Ulrike Nitschke

  2. MVZ III der evidia MVZ Halle (Saale) GmbH, Onkologie, Niemeyerstr. 22 | Eingang Nr. 23, 06110 Halle (Saale), Halle (Saale), Deutschland

    Timo Behlendorf

  3. Innere Medizin II, Städt. Krkhs. Martha-Maria, Röntgenstr. 1, 6120, Halle, Deutschland

    Wolfgang Schütte

  4. Krankenhaus Neukölln/Vivantes Kl., ChÄ d. Abt. für Strahlentherapie u. Nuklearmedizin, Rudower Str. 49, 12351, Berlin, Deutschland

    Petra Feyer

Authors
  1. Ulrike Nitschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Timo Behlendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wolfgang Schütte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Petra Feyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nitschke, U., Behlendorf, T., Schütte, W. et al. Tumorassoziierte Hyperkalzämie. Im Fokus Onkologie 26, 46–49 (2023). https://doi.org/10.1007/s15015-023-3152-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-023-3152-z

Search

Navigation